Closed System Drug Transfer Devices

closed system drug transfer


Closed System Drug Transfer Devices to 2026 • CST929F • February 2021 • US $2,850 


 

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that – in spite of promising new drugs based on therapeutic antibodies – continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues.

 

Dual chamber syringes & injectors

dual chamber syringes & injectors

 
 
 
 

 
 
 
 

 
 

 

CSTD – What You Will Learn

• What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery?
• What are the major therapeutic demand drivers for cytotoxic drug therapeutics?
• What are the design factors and technologies that are being used in commercial and development-stage closed drug transfer systems?
• What is the market share and product position in the market and what will it look like in 2026?
• Who are the companies behind the current generation of cytotoxic transfer devices and what are their business models?
• What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging closed system drug transfer devices?
• What is the impact of economic, technology, and regulatory factors on CSDT device demand?

 

CSTD – Summary of Contents

Executive Summary
Oncology Drug Trends
The Evolution in Oncology Therapeutics
Chemotherapy
Immunotherapy
The Evolving Role of Cytotoxic Drugs
The Recombinant Drug Ecosystem
CSTD Market Dynamics
Pharmacy
Point-of-Care
Technology Factors
CSDT Competitive Landscape
Risks and Opportunities
The Market for Cytotoxic Drugs
Evolving Prescribing Factors
Closed System Drug Transfer Design Factors
Oncology Therapeutics Medication Safety
Material Selection Issues
Drug Reconstitution
Oncology Drug Administration and Dosing
Drug-Specific Dosing Modification and Individualized Dosing
CSDT Device Performance Factors
Vapor Containment
Testing Protocols
CSDT Devices – Key Market Segments
Teaching Hospitals
Regional/Community Hospitals
Oncology Centers/Clinics
Closed Drug Transfer – Device Assessments
Market Assessments and Forecasts
Geographic Data
Company Profiles

 


Click HERE for more information